Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in CNSY — Cerenome, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to CNSY Full portfolio

Position in CNSY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,901
+$26,901 QoQ
Shares Held
6,156
+11515.1% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 22 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNSY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,878 across 417 Biotechnology names. CNSY ranks #306 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in CNSY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,901 6,156
2026-03-31 — 53
2025-12-31 — 53
2025-09-30 — 53
2025-06-30 — 357
2024-03-31 — 35
2023-12-31 — 35
2023-09-30 — 21
2023-06-30 — 18
2023-03-31 — 234
2022-12-31 — 230
2022-09-30 — 151
2022-06-30 — 150
2022-03-31 — 131
2021-12-31 — 96
2021-09-30 — 75
2021-06-30 — 137
2021-03-31 — 60
2020-12-31 — 30
2020-09-30 — 26
2020-06-30 — 26
2020-03-31 — 26